Procter & Gamble Health Limited

BSE:500126 Stock Report

Market Cap: ₹84.1b

Procter & Gamble Health Past Earnings Performance

Past criteria checks 4/6

Procter & Gamble Health has been growing earnings at an average annual rate of 7.5%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 7% per year. Procter & Gamble Health's return on equity is 40.5%, and it has net margins of 18.8%.

Key information

7.5%

Earnings growth rate

7.5%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate7.0%
Return on equity40.5%
Net Margin18.8%
Next Earnings Update12 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Procter & Gamble Health makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:500126 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2411,5972,1772,1380
30 Jun 2411,5132,0102,6820
31 Mar 2411,6862,1402,6800
31 Dec 2312,3702,2673,0920
30 Sep 2312,3702,3142,8450
30 Jun 2312,2962,2952,8110
31 Mar 2312,2432,4083,0300
31 Dec 2211,7122,3282,8730
30 Sep 2211,3922,0082,8070
30 Jun 2211,1441,9252,7760
31 Mar 2211,0391,8532,5480
31 Dec 2110,5521,4992,4730
30 Sep 2110,1761,7292,3720
30 Jun 2110,0871,7682,4260
31 Mar 219,2191,8842,6900
31 Dec 209,3082,1912,5770
30 Sep 209,2741,8942,5450
30 Jun 208,8861,6592,4730
31 Mar 209,2371,6451,1710
31 Dec 199,2661,5881,2420
30 Sep 198,9421,3402,4380
30 Jun 198,9521,3942,4240
31 Mar 198,8191,2812,4280
31 Dec 188,4901,0172,4280
30 Sep 1812,2901,3492,9140
30 Jun 1812,0871,1402,9130
31 Mar 1811,7621,0182,8260
31 Dec 176,9816102,0760
30 Sep 1710,5238282,3870
30 Jun 1710,0887972,3600
31 Mar 1710,1778231,5460
31 Dec 169,9267912,3470
30 Sep 169,8107232,2950
30 Jun 169,6815721,8350
31 Mar 169,5895621,2820
31 Dec 159,3835362,1070
30 Sep 159,1484013,033110
30 Jun 158,7984513,006110
31 Mar 158,7124932,957110
31 Dec 148,6624321,8890
30 Sep 148,5445162,73086
30 Jun 148,4094982,68486
31 Mar 148,0824552,67386

Quality Earnings: 500126 has high quality earnings.

Growing Profit Margin: 500126's current net profit margins (18.8%) are higher than last year (18.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 500126's earnings have grown by 7.5% per year over the past 5 years.

Accelerating Growth: 500126's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 500126 had negative earnings growth (-5.9%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (20.5%).

Return on Equity

High ROE: 500126's Return on Equity (40.5%) is considered outstanding.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 22:33
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Procter & Gamble Health Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.
Ranjit KapadiaCentrum Broking Limited
Anil BurraFirstCall Research